Effectiveness and Safety of Shaoyao Gancao Decoction With Addition on the Sleep-related Leg Cramps
NCT ID: NCT05980637
Last Updated: 2023-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE2/PHASE3
60 participants
INTERVENTIONAL
2023-09-01
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chinese Medicine in Treating Insomnia
NCT06511011
Clinical Study to Assess a Dietary Supplement on Sleep Health and Quality
NCT05368909
Phase Ⅰb/Ⅱ Study of HS-10506 in Chinese Participants With Insomnia Disorder
NCT06279286
Evaluation of the Sleep-relieving Effect of Banana Peel Extract
NCT05130359
The Potential Benefit of Xiao-Yao-San Treatment in Patients With Insomnia
NCT06417515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In Chinese medicine, leg cramps, first mentioned in the book of "Huangdi Neijing" (The Yellow Emperor's Cannon of Internal Classic), is characterized by muscular spasm and contracture of a limb resulting in difficulty in relaxation and movement. SRLC is an impediment disease caused by the invasion of wind-cold damp pathogens in the muscles and sinews, together with the dual deficiency of qi and blood that fails to nourish the muscles and sinews, leading to painful contraction of muscles.
Currently, no treatments have been proven both safe and effective for SRLC. Passive stretching and deep tissue massage, which are patient-controlled maneuvers on relieving muscle tension, are usually recommended despite limited proof of effectiveness.
Shaoyao Gancao Decoction was first introduced in the book of "Shang Han Lun" (Treatise on Cold Attack) written by the venerated Physician Zhang Zhongjing in the Eastern Han dynasty. It consists of two herbs, i.e., Paeoniae Radix Alba and Glycyrrhizae Radix et Rhizoma Praeparata Cum Melle, and has the therapeutic functions of moderating painful spasms and alleviating pain. It is commonly used in Chinese medicine practice for treating abdominal pain, lack of strength in walking, spasms of the calf muscles, and restless leg syndrome. Modern pharmacological studies showed that Shaoyao Gancao Decoction possesses anti-inflammatory, analgesic and antispasmodic effects. It has been shown that the use of Shaoyao Gancao Decoction could inhibit mechanical and thermal hyperalgesia in rats with chronic compressive injury.
In 2009, a prospective observational pilot study was conducted to evaluate the effectiveness and safety of modified Shaoyao Gancao Decoction on 30 eligible subjects with SRLC in a cohort study and the result is positive.
Based on the positive results of the pilot study, it shows that SGDA is a promising herbal treatment method for SRLC, and propose a randomized, double-blinded and placebo-controlled trial to scientifically determine the effectiveness and safety of this formula for the treatment of Shaoyao Gancao Decoction with Addition (SGDA) of SRLC. Subjects will be randomized into a treatment group or placebo group for 4 weeks, and then post-treatment visits at week 6 and week 8.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Shaoyao Gancao Decoction with Addition
11g of Shaoyao Gancao Decoction with Addition granules twice daily for 4 weeks
Shaoyao Gancao Decoction with Addition
11g twice daily for 4 weeks
Placebo
11g of placebo granules twice daily for 4 weeks
Placebo
11g twice daily for 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Shaoyao Gancao Decoction with Addition
11g twice daily for 4 weeks
Placebo
11g twice daily for 4 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Complain of muscular spasm and contracture of the lower limb with difficulty in relaxation and movement at night;
* Meet the diagnostic criteria of The International Classification of Sleep Disorders (3rd Edition) for SRLC \[2\];
* Meet the syndrome differentiation of the blood stasis or blood deficiency in Traditional Chinese Medicine.
* Regular SRLC occurs at least once per week on average within past month;
* Numeric Pain Rating Scale (NPRS) ≥ 5; and
* Willing to provide written informed consent.
Exclusion Criteria
* Known serious organic disease including severe cardiovascular disease, post-stroke depression, cancer and dementia,;
* Currently on anticoagulants, antiplatelet medications, hypnotics, anxiolytics, positive inotropic drugs, corticosteroids and estrogenic and testosterone which may interfere with the study medications.
* Impaired hematological profile and liver / renal function exceeds the upper limit of the reference value by 2 times;
* Known allergic to Chinese medicines; and
* Any contraindications for taking Chinese medicines in the opinion of the investigators;
* Known history of lower limb surgery;
* Known pregnant or breast-feeding.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Lin Zhixiu
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhixiu Lin, PhD
Role: PRINCIPAL_INVESTIGATOR
Hong Kong Institute of Integrative Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hong Kong Institute of Integrative Medicine
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sleep-related Leg Cramps study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.